Blast-induced neurotrauma leads to neurochemical changes and neuronal degeneration in the rat hippocampus

NMR in Biomedicine

Volumn 25, Issue 12, 2012, Pages 1331-1339

  Sajja, Venkata Siva Sai Sujith ^a   Galloway, Matthew P ^b   Ghoddoussi, Farhad ^b   Thiruthalinathan, Dhananjeyan ^a   Kepsel, Andrea ^a   Hay, Kathryn ^c   Bir, Cynthia A ^a   Vandevord, Pamela J ^a,c  

^a Wayne State University   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

1H MRS; Apoptosis; Blast; Hippocampus; Neurotrauma

Indexed keywords

1H MRS; AMINOBUTYRIC ACIDS; AMYLOID PRECURSOR PROTEINS; APOPTOTIC MARKERS; BLAST; CASPASE-3; DIFFUSE AXONAL INJURY; ELEVATED LEVEL; GLIAL FIBRILLARY ACIDIC PROTEINS; GLUTATHIONES; HIPPOCAMPUS; N-ACETYLASPARTATE; NEURONAL FUNCTION; NEURONAL LOSS; NEUROPSYCHIATRIC DISORDER; NEUROTRAUMA; PHOSPHORYLETHANOLAMINE; RODENT MODELS;

AMINO ACIDS; CELL DEATH; MAGIC ANGLE SPINNING;

NEURONS;

4 AMINOBUTYRIC ACID; AMYLOID PRECURSOR PROTEIN; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLUTATHIONE; GLYCEROPHOSPHORYLCHOLINE; N ACETYLASPARTIC ACID; PHOSPHOETHANOLAMINE; PROTEIN BAX; PROTEIN BCL 2; SUCCINIC ACID;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AXONAL INJURY; BLAST INJURY; BRAIN LEVEL; BRAIN METABOLISM; CELL DEATH; COMPUTER PROGRAM; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MENTAL DISEASE; MITOCHONDRIAL MEMBRANE; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPECTROMETER; TRAUMATIC BRAIN INJURY;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLAST INJURIES; BLOTTING, WESTERN; BRAIN INJURIES; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS; RODENTIA;

EID: 84868116785     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2805     Document Type: Article

References (54)

1. Okie S. Traumatic brain injury in the war zone. N. Engl. J. Med. 2005; 352: 2043-2047.
2. Leung LY, VandeVord PJ, Dal Cengio AL, Bir C, Yang KH, King AI. Blast related neurotrauma: a review of cellular injury. Mol. Cell. Biomech. 2008; 5: 155-168.
3. Fausti SA, Wilmington DJ, Gallun FJ, Myers PJ, Henry JA. Auditory and vestibular dysfunction associated with blast-related traumatic brain injury. J. Rehabil. Res. Dev. 2009; 46: 797-810.
4. Trudeau DL, Anderson J, Hansen LM, Shagalov DN, Schmoller J, Nugent S, Barton S. Findings of mild traumatic brain injury in combat veterans with PTSD and a history of blast concussion. J. Neuropsychiatr. Clin. Neurosci. 1998; 10: 308-313.
5. Hoge CW, McGurk, D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N. Engl. J. Med. 2008; 358: 453-463.
6. Svetlov SI, Larner SF, Kirk DR, Atkinson J, Hayes RL, Wang KK. Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury. J. Neurotrauma 2009; 26: 913-921.
7. Warden D. Military TBI during the Iraq and Afghanistan wars. J. Head Trauma Rehabil. 2006; 21: 398-402.
8. Jeffrey VR, Nick LF. Bomb blast, mild traumatic brain injury and psychiatric morbidity: a review. Injury 2010; 41: 437-443.
9. Bremner JD. The relationship between cognitive and brain changes in posttraumatic stress disorder. Ann. NY Acad. Sci. 2006; 1071: 80-86.
10. McNally RJ. Cognitive abnormalities in post-traumatic stress disorder. Trends Cogn. Sci. 2006; 10: 271-277.
11. Nemeroff CB, Bremner JD, Foa EB, Mayberg HS, North CS, Stein MB. Posttraumatic stress disorder: a state-of-the-science review. J. Psychiatr. Res. 2006; 40: 1-21.
12. Kochanek PM, Bauman AR, Long JB, Dixon CE, Jenkins LW. Blast-induced traumatic brain injury and polytrauma - a critical problem begging for new insight and new therapies. J. Neurotrauma 2009; 26(6): 813-814.
13. Säljö A, Svensson B, Mayorga M, Hamberger A, Bolouri H. Low-level blasts raise intracranial pressure and impair cognitive function in rats. J. Neurotrauma 2009; 26: 1345-1352.
14. Cernak I, Wang Z, Jiang J, Bian X, Savic J. Cognitive deficits following blast injury-induced neurotrauma: possible involvement of nitric oxide. Brain Inj. 2001; 15: 593-612.
15. Gottshall KR, Hoffer ME. Tracking recovery of vestibular function in individuals with blast-induced head trauma using vestibular-visual-cognitive interaction tests. J. Neurol. Phys. Ther. 2010; 34: 94-97.
16. Pascual JM, Solivera J, Prieto R, Barrios L, López-Larrubia P, Cerdán S, Roda JM. Time course of early metabolic changes following diffuse traumatic brain injury in rats as detected by (1)H NMR spectroscopy. J. Neurotrauma 2007; 24: 944-959.
17. Vandevord PJ, Bolander R, Sajja VS, Hay K, Bir CA. Mild neurotrauma indicates a range-specific pressure response to low level shock wave exposure. Ann. Biomed. Eng. 2012; 40(1): 227-236.
18. Royo NC, Schouten JW, Fulp CT, Shimizu S, Marklund N, Graham DI, McIntosh TK. From cell death to neuronal regeneration: building a new brain after traumatic brain injury. J. Neuropathol. Exp. Neurol. 2003; 62: 801-811.
19. Xie M, Tobin JE, Budde MD, Chen CI, Trinkaus K, Cross AH, McDaniel DP, Song SK, Armstrong RC. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 2010; 69: 704-716.
20. Patel AD, Gerzanich V, Geng Z, Simard JM. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J. Neuropathol. Exp. Neurol. 2010; 69: 1177-1190.
21. Brooks WM, Friedman SD, Gasparovic C. Magnetic resonance spectroscopy in traumatic brain injury. J. Head Trauma Rehabil. 2001; 16(2): 149-164.
22. 1H-MR spectroscopy in traumatic brain injury. Neurocrit. Care 2011; 14(1): 127-133.
23. Hunter JV, Wilde EA, Tong K, Holshouser BE. Emerging imaging tools for use with traumatic brain injury research. J. Neurotrauma 2012; 29(4): 654-671.
24. Stanley JA, Pettegrew JW, Keshavan MS. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - part I. Biol. Psychiatry, 2000; 48: 357-368.
25. Moore GJ, Galloway MP. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacol. Bull. 2000; 36(2): 5-23.
26. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50(6): 1800-1805.
27. Cirstea CM, Brooks WM, Craciunas SC, Popescu EA, Choi IY, Lee P, Bani-Ahmed A, Yeh HW, Savage CR, Cohen LG, Nudo RJ. Primary motor cortex in stroke: a functional MRI-guided proton MR spectroscopic study. Stroke 2011; 42(4): 1004-1009.
28. Matthews SC, Strigo IA, Simmons AN, O'Connell RM, Reinhardt LE, Moseley SA. A multimodal imaging study in U.S. veterans of Operations Iraqi and Enduring Freedom with and without major depression after blast-related concussion. Neuroimage 2011; 54: S69-S75.
29. Macqueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol. Psychiatry 2011; 16: 252-264.
30. Dal Cengio Leonardi A, Bir CA, Ritzel DV, VandeVord PJ. Intracranial pressure increases during exposure to a shock wave. J. Neurotrauma 2011; 28: 85-94.
31. Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates, 3rd edn. Elsevier Academic Press: Amsterdam; 2008.
32. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, González RG. Quantitative neuropathology by high resolution magic angle spinning proton magneticresonance spectroscopy. Proc. Natl. Acad. Sci. USA 1997; 94: 6408-6413.
33. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993; 30: 672-679.
34. 1H spectra with LCModel. NMR Biomed. 2001; 14: 260-264.
35. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramer-Rao bounds: an evaluation tool for quantification. NMR Biomed. 2001; 14: 278-283.
36. Ghoddoussi F, Galloway MP, Jambekar A, Bame M, Needleman R, Brusilow WS. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J. Neurol. Sci. 2010; 290: 41-47.
37. Schmued LC, Hopkins KJ. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000; 874: 123-130.
38. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979; 76: 4350-4354.
39. Haan C, Behrmann I. A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. J. Immunol. Methods 2007; 318: 11-19.
40. Cernak I, Wang Z, Jiang J, Bian X, Savic, J. Ultrastructural and functional characteristics of blast injury-induced neurotrauma. J. Trauma 2001; 50: 695-706.
41. Bolaños JP, Almeida A, Moncada S. Glycolysis: a bioenergetic or a survival pathway? Trends Biochem. Sci. 2010; 35: 145-149.
42. Keller JN, Guo Q, Holtsberg FW, Brucekeller AJ, Mattson MP. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 1998; 18: 4439-4450.
43. Greco T, Fiskum G. Neuroprotection through stimulation of mitochondrial antioxidant protein expression. J. Alzheimer's Dis. 2010; 20(2): S427-S437.
44. Brustovetsky N, Dubinsky JM. Dual responses of CNS mitochondria to elevated calcium. J. Neurosci. 2000; 20(1): 103-113.
45. Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. 2006; 26: 1407-1418.
46. Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 1998; 20: 271-276.
47. Barker PB. N-acetyl aspartate - a neuronal marker? Ann. Neurol. 2001; 49: 423-424.
48. Moffet JR, Tieman SB, Weinberger DR, Coyle JT, Namboodiri AMA. N-Acetylaspartate: An Unique Molecule in Central Nervous System. Springer: New York; 2006.
49. Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S, McGowan E, Emson PC, Griffin JL. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem. Int. 2010; 56: 937-947.
50. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009; 32: 638-647.
51. Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem. Pharmacol. 2010; 79: 77-89.
52. Svetlov SI, Prima V, Kirk DR, Gutierrez H, Curley KC, Hayes RL, Wang KK. Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J. Trauma, 2010; 69: 795-804.
53. Cernak I, Merkle AC, Koliatsos VE, Bilik JM, Luong QT, Mahota TM, Xu L, Slack N, Windle D, Ahmed FA. The pathobiology of blast injuries and blast-induced neurotrauma as identified using a new experimental model of injury in mice. Neurobiol. Dis. 2011; 41: 538-551.
54. Risling M, Plantman S, Angeria M, Rostami E, Bellander BM, Kirkegaard M, Arborelius U, Davidsson J. Mechanisms of blast induced brain injuries, experimental studies in rats. Neuroimage 2011; 54: S89-S97.